Comparison of the cox model and the regression tree procedure in analysing a randomized clinical trial

Statistics in Medicine

Volumn 12, Issue 24, 1993, Pages 2351-2366

  Schmoor, Claudia ^a   Ulm, Kurt ^b   Schumacher, Martin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN TUMOR; CHEMOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; INTERMETHOD COMPARISON; MULTIVARIATE ANALYSIS; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SURVIVAL TIME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIAS (EPIDEMIOLOGY); BRAIN NEOPLASMS; CARMUSTINE; CLINICAL TRIALS; ETOPOSIDE; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS; REGRESSION ANALYSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0027731147     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.4780122411     Document Type: Article

References (49)

1. Identification of prognostic factors
2. Use of regression models: statistical aspects
3. Comparability of randomised groups
4. Covariate imbalance and random allocation in clinical trials
5. Biased estimates of treatment effects in randomized experiments with nonlinear regression and omitted covariates
6. The impact of heterogeneity on the comparison of survival times
7. Effects of omitting covariates in Cox's model for survival data
8. A quantitative study of the bias in estimating the treatment effect caused by omitting a balanced covariate in survival models
9. Selecting optimal treatment in clinical trials using covariate information
10. Importance of prognostic factors in the analysis of data from clinical trials
11. Patient subsets and variation in therapeutic efficacy
12. A Bayesian approach to the interpretation of subgroup results in clinical trials
13. Further aspects of data analysis
14. Interaction between prognostic factors and treatment
15. Assessing apparent treatment–covariate interactions in randomized clinical trials
16. Testing for qualitative interactions between treatment effects and patient subsets
17. Assessment of stratum–covariate interactions in Cox's proportional hazards regression model
18. Interpretation of results from subset analyses within overviews of randomized clinical trials
19. Non‐parametric analysis of treatment–covariate interaction in the presence of censoring
20. Strategies for subgroup analysis in clinical trials
21. Statistical tools for subset analysis in clinical trials
22. Analysis of clinical trial outcomes: Alternative approaches to subgroup analysis
23. Analysis of clinical trial outcomes: Some comments on subgroup analyses
24. A decade of progress in statistical methodology for clinical trials
25. Bayesian subset analysis in a colorectal cancer clinical trial
26. Regression models and life tables (with discussion)
27. Tree‐structured survival analysis
28. Stratification by stepwise regression, correspondence analysis and recursive partition: A comparison of three methods of analysis for survival data with covariates
29. Regression and recursive partition strategies in the analysis of medical survival data
30. Regression trees for censored data
31. A comparison of estimated proportional hazard models and regression trees
32. Exponential survival trees
33. Generalized regression tree
34. Relative risk trees for censored survival data
35. Strategien zu Auswertung einer Therapiestudie mit der Überlebenszeit als Zielkriterium
36. Strategien zur Auswertung einer Therapiestudie mit der Überlebenszeit als Zielkriterium
37. Antworten auf den Kommentar von L. Edler und C. Quintero
38. A bootstrap resampling procedure for model building: Application to the Cox regression model
39. Maximally selected rank statistics
40. A simple sequentially rejective multiple test procedure
41. Statistical aspects of cancer trials
42. A note on the calculation of expected survival, illustrated by the survival of liver transplant patients
43. Measuring prognosis using the proportional hazards model
44. Prognostic factors and risk groups: Some results given by using an algorithm suitable for censored survival data